Organogenesis Q4 Earnings Call Highlights

Fourth-quarter gross profit was $175.2 million , or 78% of net product revenue, compared with 75% in the prior-year period. Francisco attributed the change primarily to a shift in product mix.Total fourth-quarter revenue also included $0.5 million of grant income from the Rhode Island Life Science Hub, which the company said offset employee-related costs at its Smithfield facility.CFO Dave Francisco reported fourth-quarter net product revenue of $225.1 million , up 78% year-over-year and up 50% sequentially ...